NCT05520944 - Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

August 26, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

October 1, 2022

Conditions

COVID-19COVID-19 PandemicCOVID-19 Respiratory InfectionSARS CoV 2 InfectionSARS-CoV-2 Acute Respiratory Disease

Interventions

DRUG

ClorNovir® (Chlorpheniramine) 0.4% Nasal Spray

Patients will have received treatment with ClorNovir® as prescribed by their physician at the approved dose per local prescribing information, as part of their COVID-19 clinical recovery.

Trial Locations (1)

Unknown

Clinica Union Medica, Santiago de los Caballeros